Investor Relations

OPKO Launches the 4Kscore Test in Europe more »

Data Supporting Once-Weekly Dosing of hGH-CTP in Growth Hormone Deficient Pediatric Population to be Presented as a Late Breaking Presentation at the European Society of Paediatric Endocrinology Conference more »

OPKO Licensee TESARO Submits New Drug Application for Rolapitant more »

OPKO Announces Second Quarter Operating and Financial Results more »

Investor Relations

We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put OPKO Health, Inc.'s financial performance into perspective.

  • Events

  • Stock Information

Ticker OPK Exchange NYSE
Last Price 8.42 Change 0.06 down
Open 8.49 Previous Close 8.48
Day High 8.57 Day Low 8.35
52-Week High 12.95 52-Week Low 7.32
Quotes delayed at least 20 minutes. Information provided by eSignal.